← Back to all trials
Recruiting
NCT06819865
A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism
Conditions: Acute Pulmonary Embolism
Sex: All
Ages: 18 Years – N/A
Enrollment: 30
Sponsor: Boston Scientific Corporation
Location: The first Affiliated Hospital, Sun Yat-sen University Guangzhou Guangdong
Summary
This study to collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.
Eligibility Criteria
Inclusion Criteria:
1. The patients with acute symptomatic pulmonary embolism (Symptomatic duration \< 14 days).
2. The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image
3. Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.
Exclusion Criteria:
1. The patients with acute symptomatic pulmonary embolism (Symptomatic duration \< 14 days).
2. The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image
3. Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.
Source: ClinicalTrials.gov (NCT06819865). StuddyBuddy aggregates publicly available trial information.
